Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 11
1977 26
1978 41
1979 65
1980 82
1981 63
1982 65
1983 62
1984 69
1985 53
1986 76
1987 70
1988 70
1989 77
1990 70
1991 61
1992 70
1993 72
1994 58
1995 61
1996 75
1997 64
1998 86
1999 63
2000 86
2001 76
2002 86
2003 93
2004 92
2005 134
2006 131
2007 157
2008 176
2009 196
2010 205
2011 242
2012 256
2013 223
2014 185
2015 189
2016 171
2017 165
2018 165
2019 168
2020 170
2021 100
2022 79
2023 23
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

4,630 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Progesterone Receptors in Breast Cancer.
Li Z, Wei H, Li S, Wu P, Mao X. Li Z, et al. Drug Des Devel Ther. 2022 Jan 26;16:305-314. doi: 10.2147/DDDT.S336643. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35115765 Free PMC article. Review.
Pathology of triple negative breast cancer.
Borri F, Granaglia A. Borri F, et al. Semin Cancer Biol. 2021 Jul;72:136-145. doi: 10.1016/j.semcancer.2020.06.005. Epub 2020 Jun 13. Semin Cancer Biol. 2021. PMID: 32544511 Review.
Progesterone and Breast Cancer.
Trabert B, Sherman ME, Kannan N, Stanczyk FZ. Trabert B, et al. Endocr Rev. 2020 Apr 1;41(2):320-44. doi: 10.1210/endrev/bnz001. Endocr Rev. 2020. PMID: 31512725 Free PMC article. Review.
Progesterone activates GPR126 to promote breast cancer development via the Gi pathway.
An W, Lin H, Ma L, Zhang C, Zheng Y, Cheng Q, Ma C, Wu X, Zhang Z, Zhong Y, Wang M, He D, Yang Z, Du L, Feng S, Wang C, Yang F, Xiao P, Zhang P, Yu X, Sun JP. An W, et al. Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2117004119. doi: 10.1073/pnas.2117004119. Epub 2022 Apr 8. Proc Natl Acad Sci U S A. 2022. PMID: 35394864 Free PMC article.
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, Perou CM, Regan MM, Rimm DL, Symmans WF, Torlakovic EE, Varella L, Viale G, Weisberg TF, McShane LM, Wolff AC. Allison KH, et al. J Clin Oncol. 2020 Apr 20;38(12):1346-1366. doi: 10.1200/JCO.19.02309. Epub 2020 Jan 13. J Clin Oncol. 2020. PMID: 31928404
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update.
Burstein HJ, Somerfield MR, Barton DL, Dorris A, Fallowfield LJ, Jain D, Johnston SRD, Korde LA, Litton JK, Macrae ER, Peterson LL, Vikas P, Yung RL, Rugo HS. Burstein HJ, et al. J Clin Oncol. 2021 Dec 10;39(35):3959-3977. doi: 10.1200/JCO.21.01392. Epub 2021 Jul 29. J Clin Oncol. 2021. PMID: 34324367 Free PMC article.
4,630 results